David Geffen School of Medicine UCLA — Los Angeles, California

David Geffen School of Medicine UCLA is a clinical research site located in Los Angeles, California, United States 90095.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

David Geffen School of Medicine UCLA has participated in 8 clinical trials.

Therapeutic areas: Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension, Metastatic Renal Cell Carcinoma.

Sponsors: Gilead Sciences, NewLink Genetics Corporation, Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for David Geffen School of Medicine UCLA?

David Geffen School of Medicine UCLA has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has David Geffen School of Medicine UCLA conducted?

David Geffen School of Medicine UCLA has 8 clinical trials on record. Their work covers Idiopathic Pulmonary Fibrosis, Pulmonary Hypertension, Metastatic Renal Cell Carcinoma.

Is David Geffen School of Medicine UCLA accredited by Crixeo Health?

Yes — David Geffen School of Medicine UCLA holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about David Geffen School of Medicine UCLA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.